Hopital Erasme — Clinical Trial Site

233 Registered trials

79 Currently recruiting

Organisation

Hopital Erasme

Location

Anderlecht, Belgium

Identifier

ORG-100019366

Address

Lennikse Baan 808, 1070, Belgium

Departments

/
#1201:Dermatology
#161: Gastroenterologie-oncologie
#3051: Cardiology
#40123:Rhumatologie
#7052: Dermatology
#9143: Dermatology
#92: Pneumology Unit
#BE10005: Gastro-Entérologie
056001:Cardiologie
1004:Dermatology
1303: Maladies Infectieuses
2511: Dermatology
3004: Neurology
3051:Cardiology
40123: Neurologie
9115 : Neurology
Adult
Anaesthesiology
Anesthesiology
Campus Erasme
Cardiologie
Cardiology
Cardioloy
Center for Reproductive Medicine
Centre Hospitalier le "Domaine"-ULB
Clinic of Infectious & Tropical Diseases
Clinical Research - Gastroenterology Department
Clinique de fertilité
Clinique des Maladies infectieuses
Cliniques Universitaires de Bruxelles Hopital Erasme
Department of Cardiology
Department of Dermatology
Department of Gastroenterology, Hepato-Pancreatology and Digestive Oncology
Department of Gastroenterology/Hepatopancreotology
Department of Intensive Care
Department of Neurology
Department of Surgery
Department of Urology
Dept of Gastroenterology/HepatoPancreatology/Digestive Oncology
Dermatologie
Dermatology
Dermatology Department
Digestive Oncology
Division of Endocrinology
Endocrinologie
Endocrinology
EPIV - Infectious Diseases
Gastro Enterology
Gastro-enterologie
Gastro-Enterology
Gastro-enterology and digestive oncology
Gastroentérologie
Gastroentérologie médicale
Gastroenterology
Gastroenterology & Hepatology
Gastroenterology and GI oncology
Gastroenterology Department
Gastroenterology, Hepatopancreatology and Digestive Oncology
Gastroenterology/ HepatoPancreatology/Digestive Oncology
Gastroenterology/Hepagestive Oncology
Gastroenterology/HepatoPancreatology/Digestive Oncology
General Internal Diseases
Gynécologie - Obstétrique
Gynécologie-Obstétrique
Haematology
Haematology Department
HUB Erasme
Infectious and tropical diseases
Infectious disease
Infectious diseases
Intensive Care
Intensive Care Unit
Internal medicine
N/A
NA
Neonatology
Nephrology
Nephrology department
Neurology
neurosurgery department
Oncology
Patient Visit
Pneumologie
Pneumology
Pneumology department
Pneumology department Level -1, Route 693
Pneumology unit
Psychiatry
Pulmonary Hypertension
Pulmonology
Rheumatology
Rheumatology and Physical Medicine
Service de Neurologie, Erasme-HUDERF Neuromuscular Reference Center (CRNM)
Service Pneumologie
ULB Hopital Erasme
Urology

Clinical trials at this site (233)

Search interface

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn’s Disease and Obesity or Overweight:… Recruiting

2024-520210-21-00 Crohn’s Disease 5 2025-09-19
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) Recruiting

2024-513613-12-00 Part A: Healthy volunteers (Part A is not applicable to 9 2025-09-18
Study of Ruxolitinib Cream in Participants with Hidradenitis Suppurativa (TRuE-HS2) Recruiting

2024-517633-40-00 Hidradenitis Suppurativa 5 2025-09-18
A study to evaluate the efficacy and safety of ruxolitinib cream in children (6 to <12 years old) with non-segmental vitiligo Recruiting

2024-513171-41-00 Vitiligo 5 2025-09-11
An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR compared to Mexiletine IR in Patients wi… Recruiting

2024-514970-27-00 Non-Dystrophic Myotonias (NDM) 5 2025-09-03
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn’s Disease (CD) Recruiting

2024-518914-18-00 Moderate to Severely Active Ulcerative Colitis & Modera 4 2025-08-27
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) Recruiting

2024-517529-26-00 Chronic Inflammatory Demyelinating Polyneuropathy 5 2025-08-04
A pHase III cluster randomIsed controlled, cross-over, non-inferiority Trial of a short course, High dose AntimicRobials vs conventional dos… Recruiting

2024-514730-21-00 Bacterial infections and mycoses 5 2025-07-01
A study to understand if sotagliflozin improves symptoms and is safe in people with hypertrophic cardiomyopathy Recruiting

2024-513869-39-00 Obstructive Cardiomyopathy, Hypertrophic 5 2025-06-27
A Study of Zasocitinib in Adults with Psoriatic Arthritis Who Have Not Taken Biologic Medicines Recruiting

2024-513111-27-00 Psoriatic Arthritis 5 2025-06-26
A Phase 2b Study to Assess the Efficacy and Safety of IMVT-1402 in Patients with Grave’s Disease Recruiting

2024-516020-33-00 Grave’s Disease 4 2025-06-26
A Study to Compare the Efficacy and Safety of Vedolizumab With and Without Upadacitinib in Adults With Moderately to Severely Active Crohn's… Recruiting

2023-509391-42-00 Chron's Disease 11 2025-06-02
Development of an optimized dosing regimen of ceftazidime-avibactam in critically ill patients treated with continuous renal replacement the… Recruiting

2023-505536-35-00 Ceftazidime-avibactam therapy in critically ill patient 6 2025-05-04
Treatment of ELectroencephalographic STatus epilepticus After cardiopulmonary Resuscitation-2 (TELSTAR-2): a multicenter randomised clinical… Recruiting

2024-516068-27-01 cardiopulmonary resuscitation 5 2025-04-10
A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects … Recruiting

2023-504904-26-00 Progressive Pulmonary Fibrosis 5 2025-04-07
Hypertonic lactate after cardiac arrest Recruiting

2023-506031-15-01 post-anoxic brain injury 4 2025-02-18
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease ( ENHANCE-CD ) Recruiting

2023-508234-34-00 Crohn's disease 4 2025-01-27
A WORLD-WIDE CLINICAL STUDY TO FIND OUT IF INTRAVENOUS RECOMBINANT HUMAN PLASMA GELSOLIN IS SAFE AND IS BENEFICIAL FOR TREATING ACUTE RESPIR… Recruiting

2023-510109-16-00 Acute Respiratory Distress Syndrome (ARDS) Due to Pneum 4 2025-01-06
A study to determine if BHV-7000 is safe in adults with refractory focal onset epilepsy Recruiting

2023-508813-18-00 Refractory Focal Onset Epilepsy 4 2024-12-18
A Phase 3 efficacy and safety study of fosmanogepix for the treatment of adult participants with candidemia and/or invasive candidiasis. Recruiting

2022-500455-23-00 Candidemia 5 2024-12-11
Proactive TDM versus standard use of biologics in psoriasis (HELIOS) Recruiting

2023-509637-39-00 moderate-to-severe psoriasis 6 2024-11-28
Study of Targeted Therapies for the Treatment of Adult Participants with Moderate to Severe Crohn’s Disease Recruiting

2024-513009-30-00 Moderate to Severe Crohn’s Disease 4 2024-11-21
An open-label study to assess reduction of daily asthma medication with tezepelumab in patients 12 to 80 years of age with severe asthma Recruiting

2024-512113-41-00 Severe Asthma 5 2024-11-20
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-fibrosis) Recruiting

2023-509912-27-00 Metabolic Dysfunction-Associated Steatotic Liver Diseas 5 2024-11-07